| International Nonproprietary N |
Proposed INN: List 119 | WHO Drug Information,2018,32,2 | view |
| ATC/DDD classification |
ATC/DDD classification (final) | WHO Drug Information,2018,32,2 | view |
| ATC/DDD classification |
ATC/DDD classification (temporary) | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Other recent WHO consultation documents | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Proposal for revision of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving inInternational Commerce | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Inquiry regarding production of water for injections | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Polymorphism | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Daclatasvir tablets(Daclatasviri compressi) | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Daclatasvir dihydrochloride(Daclatasviri dihydrochloridum) | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Atazanavir capsules(Atazanaviri capsulae) | WHO Drug Information,2018,32,2 | view |
| Consultation documents |
Atazanavir sulfate(Atazanaviri sulfas) | WHO Drug Information,2018,32,2 | view |
| Publications and events |
Joint UNFPA-UNICEF-WHO meeting | WHO Drug Information,2018,32,2 | view |
| Publications and events |
18th International Conference of Drug Regulatory Authorities (ICDRA) | WHO Drug Information,2018,32,2 | view |
| Publications and events |
78th FIP World Congress of Pharmacy and Pharmaceutical Sciences | WHO Drug Information,2018,32,2 | view |
| Publications and events |
WHO-UMC-HSA Inter-Regional Pharmacovigilance Training workshop | WHO Drug Information,2018,32,2 | view |
| Publications and events |
Pakistan joins collaborative registration | WHO Drug Information,2018,32,2 | view |
| Publications and events |
Additional medicines invited | WHO Drug Information,2018,32,2 | view |
| Publications and events |
“Firsts” | WHO Drug Information,2018,32,2 | view |
| Publications and events |
New WHO stability guideline published | WHO Drug Information,2018,32,2 | view |
| Publications and events |
WHO prequalification updatesICH Q3D introduced for APIs | WHO Drug Information,2018,32,2 | view |
